Manufacturers Drug Coated Stents

Manufacturers of Drug Coated Stents: Targets of Blood Clot Lawsuits

The manufacturers of drug coated stents, Boston Scientific and Johnson & Johnson, could end up rivaling Merck, maker of Vioxx, as likely targets for lawsuits from people who suffer heart attacks and thrombosis blood clots.

Do You Have a Drug Eluting Stents Lawsuit? »

Boston Scientific recently came out and said that there were problems with drug coated stents which also alluded to the Johnson & Johnson of having the same problems with their drug coated stents. The drug coated stent industry earned $5.4 billion dollars last year and with this new pivotal and very public concern, sales are not predicted to plummet.

While many medical device manufacturers have recently invested heavily in a special kind of drug-coated stent that is supposed to keep diseased arteries from closing back up, many Wall Street analyst and investors believe that the stent industry has a broken heart. The growth prospects for drug-eluting stents are poor as safety concerns are making the drug coated stent markets sluggish.

Contact Our Drug Coated Stents Lawyers Today »

However, these mega billion dollar companies still have deep pockets. The concern is not if and how they can please their bottom line and investors but what is going to happen to all people who are walking around with these time bomb tainted drug coated stents already implanted in their bodies?

Talk to a Lawyer